Dr. Allen Benjamin Yeroushalmi, MD

Dr. Yeroushalmi practices at Oakhurst Surgical Center, LLC in Beverly Hills, California.

Dr. Yeroushalmi's NPI, 1952562159, was assigned on June 19, 2008. Dr. Yeroushalmi graduated from Albert Einstein College of Medicine in 2008. Dr. Yeroushalmi holds California license A112058.

Dr. Yeroushalmi's primary practice is Oakhurst Surgical Center, LLC, at 9001 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 273-8094.

Dr. Yeroushalmi's primary practice is Oakhurst Surgical Center, LLC in Beverly Hills, California. Dmand AI also links Dr. Yeroushalmi to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yeroushalmi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Yeroushalmi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Yeroushalmi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Yeroushalmi's licenses on file in 4 states: California, Delaware, New York and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Yeroushalmi treats.

CMS data shows 1,536 Medicare services from Dr. Yeroushalmi across 16 procedure codes in 2024, for 262 Medicare patients. Medicare paid $94,857 for them.

CMS counts 262 Medicare patients who saw Dr. Yeroushalmi in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yeroushalmi's median patient age at 64, with 53% women.

In 2024, Dr. Yeroushalmi wrote 318 Medicare Part D claims for 75 patients. 51% of them were for generic drugs. CMS names the drug for 237 of them, across 5 drugs with 11 or more claims each, at $13,001 in total drug cost. In 2023, CMS named 251 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yeroushalmi for performance year 2024, reported as part of a group. Dr. Yeroushalmi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of cataract surgery by Dr. Yeroushalmi, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Yeroushalmi in 2014. Dr. Yeroushalmi's most frequent co-author is Derek D. Huang, MD.

CMS Open Payments shows 24 general payments to Dr. Yeroushalmi from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Alcon Laboratories Inc paid the most, $4,449.

Dr. Yeroushalmi graduated from Albert Einstein College of Medicine in 2008.

Dr. Yeroushalmi is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.